Is RPG LifeScience. overvalued or undervalued?

Nov 01 2025 08:05 AM IST
share
Share Via
As of October 31, 2025, RPG LifeScience is fairly valued with a PE ratio of 35.76, a PEG ratio of 0.84 indicating growth potential, and strong operational efficiency reflected in its ROCE of 46.94% and ROE of 21.01%, while outperforming the Sensex recently.
As of 31 October 2025, RPG LifeScience has moved from an expensive to a fair valuation grade. The company is currently fairly valued, with a PE ratio of 35.76, a Price to Book Value of 7.51, and an EV to EBITDA ratio of 24.94. Notably, its PEG ratio stands at 0.84, indicating potential for growth relative to its price.

In comparison to peers, RPG LifeScience's PE ratio is slightly higher than Sun Pharma's at 35.35 but significantly lower than Divi's Lab's exorbitant 77.85. Additionally, while Cipla presents a more attractive valuation with a PE of 22.29, RPG LifeScience's strong ROCE of 46.94% and ROE of 21.01% suggest robust operational efficiency. Recent stock performance shows RPG LifeScience outperforming the Sensex over the past week and month, reinforcing its fair valuation amidst a competitive landscape.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News